Latest Regulatory Milestones News

Imagion Biosystems has made significant progress towards filing an Investigational New Drug application for its MagSense® HER2 breast cancer imaging agent, receiving encouraging feedback from the FDA and preparing for a Phase 2 clinical trial.

Osteopore Limited reports a three-fold increase in craniofacial implant sales within a year of signing an exclusive distribution deal with Zimmer Biomet, signaling strong early traction across key global markets.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 amid promising regulatory and market developments.

Capricorn Metals has received regulatory approval to expand its Karlawinda operations, enabling a 25% increase in gold production to 150,000 ounces annually. Construction is set to accelerate with key contracts extended and infrastructure upgrades underway.

Brazilian Critical Minerals Ltd has reported significant progress at its Ema rare earths project, achieving high recovery rates from in-situ recovery (ISR) tests and securing a $4 million capital raise to accelerate development.

Morella Corporation has secured key heritage approvals and government co-funding, while prioritising rubidium extraction research ahead of drilling at its Mt Edon and Mallina projects.

BPH Energy’s June quarter update highlights ongoing legal proceedings over the PEP-11 permit, promising progress in AI-driven brain monitoring technology, and strategic moves toward hydrogen production facilities, supported by a robust cash reserve.

Peninsula Energy advances commissioning at its Lance uranium project, resets most sales contracts to reduce risk, and secures a $15 million debt facility to support production ramp-up.

VRX Silica Limited has successfully concluded the environmental appeal process for its Arrowsmith North Silica Sand Project, with the WA Minister for Environment confirming the adequacy of the EPA assessment. The company is now advancing financing discussions and offtake agreements as it awaits formal project approval.

PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.

Latrobe Magnesium Limited has extended its Pilot Project Licence with EPA Victoria until February 2027, paving the way to resume magnesium oxide production at its Hazelwood North site in August 2025.

Winsome Resources progresses key permitting and exploration milestones at its Adina Lithium Project while maintaining a strong cash position and deferring the Renard Option decision amid subdued lithium market conditions.